Characteriza*on of Soma*c Muta*ons in Cancer Genomes

Size: px
Start display at page:

Download "Characteriza*on of Soma*c Muta*ons in Cancer Genomes"

Transcription

1 Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology

2 Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger muta*ons Founder cell typical tumor : Driver muta*on Time (cell divisions) ~10 driver muta*ons 100 s 1000 s of passenger muta*ons Cell popula*on CGTAATTAG CGTCATTAG Single nucleo*de variant Copy number variants Structural variants

3 Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger muta*ons Founder cell typical tumor : Driver muta*on Time (cell divisions) ~10 driver muta*ons 100 s 1000 s of passenger muta*ons Cell popula*on Sequence genome

4 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing CATTCAGTAG GGTAGTTAG TATAATTAG AGCCATTAG GGTAAACTAG CGTACCTAG s million reads Read: bp Genome and Muta6ons

5 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. 1. De novo assembly Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing 2. Resequencing CATTCAGTAG GGTAGTTAG TATAATTAG AGCCATTAG GGTAAACTAG CGTACCTAG s million reads Read: bp

6 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. 1. De novo assembly Algorithms Human genome: ~3 billion bp Next- genera6on DNA sequencing 2. Resequencing Right breakpoint (a,b) Geometric Analysis of Structural Varia*on (GASV) Lea breakpoint Bashir, et al. PLOS Comp. Biol. (2008) Sindi et al. Bioinforma3cs/ISMB (2009), Sindi et al. (2011) [In revision] GASVPro

7 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms gene Human genome: ~3 billion bp Next- genera6on DNA sequencing Reads of bp Genome and Muta6ons 2. Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.

8 Driver Muta*ons Next- genera*on DNA sequencing gene : soma*c muta*on Recurrent muta*ons/mutated genes à driver muta*ons Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.

9 Recurrent Muta*ons genes pa6ents f Muta6on matrix = mutated = 1 = not mutated = 0 gene : soma*c muta*on Mutated more that expected by chance? Single- gene test à Mul*ple hypotheses correc*on 91 GBM samples. TCGA, Nature (2008) 316 OV samples. TCGA, Nature (2011) Table 2 Significantly mutated genes in HGS-OvCa Gene No. of mutations No. validated No. unvalidated TP BRCA CSMD NF CDK FAT GABRA BRCA RB Validated mutations are those that have been confirmed with an independent assay. Most of them are

10 Mutated Pathways Standard approach: enrichment of muta*ons on known pathways. genes pa6ents p53 pathway: 87% of pa*ents Limita6ons Only exis*ng pathways are tested. Topology of pathways ignored. Pathways are interconnected (crosstalk). TCGA GBM. Nature, 2008.

11 Pathways à Groups " The view that muta*ons affect discrete signaling pathways...has proved to be too simplis*c. [Cancer genes] depend on one another for their selec*ve advantage, and they affect mul1ple pathways that intersect and overlap. Frank McCormick, Signalling networks that cause cancer, Trends in Gene3cs (1999).

12 Advantage of Large Datasets? Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge Number of Hypotheses (< 6 genes) (< 6 genes)

13 Two Algorithms Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets

14 HotNet: Problem Defini*on Given: 1. Network G = (V, E) V = genes. E = interac*ons b/w genes 2. Binary muta*on matrix Genes = mutated = not mutated Pa6ents Find: Connected subnetworks mutated in a significant number of pa*ents mutated in pa*ent if 1 gene mutated in pa*ent

15 (Local) Topology Maoers Single path between mutated genes Path between mutated genes is one of many through node. Example: TP53 has 238 neighbors in HPRD network

16 Heat Diffusion on Graph

17 Mutated subnetworks: HotNet* Muta6on Matrix Genes Human Interac6on Network = mutated genes Pa*ents (1) Muta6on heat diffusion Extract significantly hot subnetworks Hot (2) Cold *F. Vandin, E. Upfal, and B. J. Raphael. J. Comp.Biol. (2011). Also RECOMB (2010).

18 Sta*s*cal Test Muta6on Matrix Genes Random Binary Matrix Genes Pa*ents Pa*ents X s = number of subnetworks s genes Two- stage mul6- hypothesis test: Rigorously bound FDR.

19 HPRD network nodes edges Results: TCGA Ovarian ~20000 Genes 316 Pa*ents Muta*on & copy number HotNet 27 subnetworks with 7 genes (P < 0.03) TCGA. Nature (2011)

20 Ovarian Subnetworks TCGA. Nature (2011)

21 Ovarian Subnetworks Kegg Pathway Notch signaling (p < 6x10-7 ) 12/27 subnetworks significantly overlap known pathways (KEGG) or protein complexes (PINdb) TCGA. Nature (2011)

22 Ovarian Subnetworks Known Protein Complexes Cohesin (P < 5x10-8 ) Kegg Pathway Cell cycle (P < 2x10-5 ) TCGA. Nature (2011)

23 Results: Brain Cancer 91 Samples HPRD network nodes edges 601 Genes Muta*on & copy number HotNet 2 subnetworks with 20 genes (P < 0.01)

24 Brain: Muta*ons + Copy number RTK/RAS/PI(3)K RB1 p53 Subnetwork Enrichment p- val s RTK/RAS/PI(3)K P53 RB x10-6 4x

25 Two Algorithms Prior knowledge of groups of genes Known pathways Interac*on Network None Prior knowledge HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets

26 Pathways and Muta*ons Driver muta3ons are rare. Cancer pathway has one driver muta*on (gene) per pa*ent [Vogelstein and K. W. Kinzler (2004), Yeang, McCormick, and Levine (2008)] 1. Exclusivity Genes EGFR RAF cell membrane RAS MEK Pa6ents MAPK Transcrip*on factors [Thomas, et al. (2007)]

27 Pathways and Muta*ons Driver muta3ons are rare. Cancer pathway has one driver muta*on (gene) per pa*ent [Vogelstein and K. W. Kinzler (2004), Yeang, McCormick, and Levine (2008)] 1. Exclusivity EGFR RAF cell membrane RAS Many pa*ents have muta*on in important cancer pathway. 2. Coverage MAPK MEK Transcrip*on factors

28 De novo driver exclusivity (Dendrix*) Given: Binary muta*on matrix A Find: Set M of genes with: Maximum Coverage: maximum number of pa*ents have 1 muta*on in M Mutual Exclusivity: all pa*ents have 1 muta*on in M pa6ents ; genes Difficult computa*onal problem (NP- hard) *Vandin, Upfal, & Raphael. Genome Res. (Advance online) Also RECOMB 2011.

29 De novo driver exclusivity (Dendrix*) Given: Binary muta*on matrix A Find: Set M of genes with: High Coverage: many pa*ents have a 1 muta*on in M Approximate Exclusivity: most pa*ents have 1 muta*on in M Finding largest M is difficult! Greedy algorithm and MCMC algorithm Theore*cal results on convergence and op*mality. pa6ents ; genes Dendrix++: extension with scoring based on probabilis*c model *Vandin, Upfal, & Raphael. Genome Res. (Advance online) Also RECOMB 2011.

30 Experimental Results Cancer data 1. Known muta6ons in mul6ple cancer types [Thomas et al. (2007)] 238 known muta*ons in 1000 pa*ents of 17 different cancer types 2. Lung Adenocarcinoma [Ding et al. (2008)] 623 sequenced genes in 188 pa*ents 3. Brain cancer (GBM) [TCGA (2008)] 601 sequenced genes in 84 pa*ents Array copy number data on all genes 4. Acute Myleloid Leukemia (AML) [TCGA] Whole exome sequencing on ~200 pa*ents 5. Breast Cancer (BRCA) [TCGA] Whole exome sequencing Array copy number on ~400 pa*ents

31 Known muta*ons in mul*ple cancer types 238 known muta*ons tumors from 17 cancer types [Thomas, et al. (2007)] Muta*on: Exclusive Co- occurring None 8 muta*ons cover 94% of mutated tumors Only 15 tumors with >1 muta*on (p < 0.01)

32 Lung Adenocarcinoma 623 sequenced genes in 188 pa*ents [Ding et al. (2008)] (p < 0.01) (p < 0.01)

33 Brain Cancer (GBM) Muta*ons (single- nucleo*de and copy number) for 601 genes in 84 samples [TCGA (2008)] (p < 0.01) (p < 0.01) (p < 0.01)

34 Challenges in Cancer Genomics 1. Measurement of all soma*c muta*ons. Algorithms gene Human genome: ~3 billion bp Next- genera6on DNA sequencing Reads of bp Genome and Muta6ons 2. Dis6nguish func*onal (driver) muta*ons from background (passenger) muta*ons.

35 Summary Prior knowledge of groups of genes Known pathways Prior knowledge Interac*on Network None HotNet subnetworks of interac*on network Number of Hypotheses Dendrix Exclusive gene sets Future: Incorporate more data types (methyla*on, gene expression). Perform pre/post filtering of predic*ons.

36 Acknowledgements Fabio Vandin Eli Upfal Hsin- Ta Wu Edward Rice Tim Ley Li Ding Elaine Mardis Rick Wilson and others Funding

37 Shameless Adver*sing 1) Soaware available. 2) Student* and postdoc posi6ons available. * Ph.D. programs in Computer Science, Computa*onal Biology, and Molecular Biology. Web: hop://cs.brown.edu/people/braphael

Simultaneous Identification of Multiple Driver Pathways in Cancer

Simultaneous Identification of Multiple Driver Pathways in Cancer Simultaneous Identification of Multiple Driver Pathways in Cancer Mark D. M. Leiserson 1, Dima Blokh 2, Roded Sharan 2., Benjamin J. Raphael 1. * 1 Department of Computer Science and Center for Computational

More information

A Robust Method for Identifying Mutated Driver Pathways in Cancer

A Robust Method for Identifying Mutated Driver Pathways in Cancer , pp.392-397 http://dx.doi.org/10.14257/astl.2016. A Robust Method for Identifying Mutated Driver Pathways in Cancer Can-jun Hu and Shu-Lin Wang * College of computer science and electronic engineering,

More information

AML Genomics 11/27/17. Normal neutrophil maturation. Acute Myeloid Leukemia (AML) = block in differentiation. Myelomonocy9c FAB M5

AML Genomics 11/27/17. Normal neutrophil maturation. Acute Myeloid Leukemia (AML) = block in differentiation. Myelomonocy9c FAB M5 AML Genomics 1 Normal neutrophil maturation Acute Myeloid Leukemia (AML) = block in differentiation AML with minimal differen9a9on FAB M1 Promyelocy9c leukemia FAB M3 Myelomonocy9c FAB M5 2 1 Principle

More information

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics, 2010 C.J.Vaske et al. May 22, 2013 Presented by: Rami Eitan Complex Genomic

More information

Understanding Genotype- Phenotype relations in Cancer via Network Approaches

Understanding Genotype- Phenotype relations in Cancer via Network Approaches AlgoCSB Algorithmic Methods in Computational and Systems Biology Understanding Genotype- Phenotype relations in Cancer via Network Approaches Teresa Przytycka NIH / NLM / NCBI Phenotypes Journal Wisla

More information

Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine

Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine Raphael et al. Genome Medicine 2014, 6:5 REVIEW Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine Benjamin J Raphael 1,2*, Jason R Dobson 1,2,3,

More information

Classifica4on. CSCI1950 Z Computa4onal Methods for Biology Lecture 18. Ben Raphael April 8, hip://cs.brown.edu/courses/csci1950 z/

Classifica4on. CSCI1950 Z Computa4onal Methods for Biology Lecture 18. Ben Raphael April 8, hip://cs.brown.edu/courses/csci1950 z/ CSCI1950 Z Computa4onal Methods for Biology Lecture 18 Ben Raphael April 8, 2009 hip://cs.brown.edu/courses/csci1950 z/ Binary classifica,on Given a set of examples (x i, y i ), where y i = + 1, from unknown

More information

Network-based interpreta1on of perturba1ons to living systems

Network-based interpreta1on of perturba1ons to living systems Network-based interpreta1on of perturba1ons to living systems Sushmita Roy sroy@biostat.wisc.edu Computa1onal Network Biology Biosta2s2cs & Medical Informa2cs 826 Computer Sciences 838 hbps://compnetbiocourse.discovery.wisc.edu

More information

Missing Heritablility How to Analyze Your Own Genome Fall 2013

Missing Heritablility How to Analyze Your Own Genome Fall 2013 Missing Heritablility 02-223 How to Analyze Your Own Genome Fall 2013 Heritability Heritability: the propor>on of observed varia>on in a par>cular trait (as height) that can be agributed to inherited gene>c

More information

Integrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers

Integrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers Integrating Genome and Functional Genomics Data to Reveal Perturbed Signaling Pathways in Ovarian Cancers Songjian Lu, PhD, Xinghua Lu, MD. PhD Dept. Biomedical Informatics, Univ. Pittsburgh, PA 15232

More information

Cancer gene discovery via network analysis of somatic mutation data. Insuk Lee

Cancer gene discovery via network analysis of somatic mutation data. Insuk Lee Cancer gene discovery via network analysis of somatic mutation data Insuk Lee Cancer is a progressive genetic disorder. Accumulation of somatic mutations cause cancer. For example, in colorectal cancer,

More information

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015 Introduction to Cancer Bioinformatics and cancer biology Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015 Why cancer bioinformatics? Devastating disease, no cure on the horizon Major

More information

Copy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015

Copy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Copy Number Varia/on Detec/on Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Today s Goals Understand the applica5on and capabili5es of using targe5ng sequencing and CNV calling

More information

Identifying Mutated Core Modules in Glioblastoma by Integrative Network Analysis

Identifying Mutated Core Modules in Glioblastoma by Integrative Network Analysis Identifying Mutated Core Modules in Glioblastoma by Integrative Network Analysis Junhua Zhang, Shihua Zhang, Yong Wang, Junfei Zhao and Xiang-Sun Zhang National Center for Mathematics and Interdisciplinary

More information

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes Nature Genetics 47, 106-114 (2015) doi:101038/ng3168 Max Leiserson RECOMB 2015 April

More information

Long non coding RNA in the pea aphid; iden3fica3on and compara3ve expression in sexual and asexual embryos

Long non coding RNA in the pea aphid; iden3fica3on and compara3ve expression in sexual and asexual embryos Long non coding RNA in the pea aphid; iden3fica3on and compara3ve expression in sexual and asexual embryos Fabrice Legeai, Thomas Derrien, Valen3n Wucher, Audrey David, Gael Le Trionnaire and Denis Tagu

More information

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why

More information

Decades of cancer research have demonstrated that. Computational approaches for the identification of cancer genes and pathways

Decades of cancer research have demonstrated that. Computational approaches for the identification of cancer genes and pathways Computational approaches for the identification of cancer genes and pathways Christos M. Dimitrakopoulos 1,2 and Niko Beerenwinkel 1,2 * High-throughput DNA sequencing techniques enable large-scale measurement

More information

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome

Genetic Tests and Genetic Counseling How to Analyze Your Own Genome Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and

More information

Structured Association Advanced Topics in Computa8onal Genomics

Structured Association Advanced Topics in Computa8onal Genomics Structured Association 02-715 Advanced Topics in Computa8onal Genomics Structured Association Lasso ACGTTTTACTGTACAATT Gflasso (Kim & Xing, 2009) ACGTTTTACTGTACAATT Greater power Fewer false posi2ves Phenome

More information

Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser

Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser Melissa S. Cline 1*, Brian Craft 1, Teresa Swatloski 1, Mary Goldman 1, Singer Ma 1, David Haussler 1, Jingchun Zhu 1 1 Center for Biomolecular

More information

Evolu&on of Disease genes

Evolu&on of Disease genes Evolu&on of Disease genes Many human diseases are caused by muta1ons in single genes A synthe&c pathway and associated diseases Autosomal dominant condi&ons Dominant Disorders A single mutant gene is sufficient

More information

Evolu+on of Disease genes

Evolu+on of Disease genes Evolu+on of Disease genes Many human diseases are caused by muta1ons in single genes 1 A synthe+c pathway and associated diseases Autosomal dominant condi+ons 2 Dominant Disorders A single mutant gene

More information

Expanded View Figures

Expanded View Figures Solip Park & Ben Lehner Epistasis is cancer type specific Molecular Systems Biology Expanded View Figures A B G C D E F H Figure EV1. Epistatic interactions detected in a pan-cancer analysis and saturation

More information

Integrative Omics for The Systems Biology of Complex Phenotypes

Integrative Omics for The Systems Biology of Complex Phenotypes Integrative Omics for The Systems Biology of Complex Phenotypes Mehmet Koyutürk Case Western Reserve University (1) Electrical Engineering and Computer Science (2) Center for Proteomics and Bioinformatics

More information

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics Copy Number Variations and Association Mapping 02-715 Advanced Topics in Computa8onal Genomics SNP and CNV Genotyping SNP genotyping assumes two copy numbers at each locus (i.e., no CNVs) CNV genotyping

More information

Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY

Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY A Somewhat Different View of the Gene3c Portrait of Chronic Lymphocy3c Leukemia Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY Acknowledgments Davide Bagnara

More information

Reconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer

Reconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer Reconstruc*ng Human Tumor Histories By Comparing Genomes From Different Parts of the Same Cancer Darryl Shibata Professor of Pathology University of Southern California Keck School of Medicine dshibata@usc.edu

More information

Epigene.cs: What is it and how it effects our health? Overview. Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa

Epigene.cs: What is it and how it effects our health? Overview. Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa Epigene.cs: What is it and how it effects our health? Dr. Bill Stanford, PhD OFawa Hospital Research Ins.tute University of OFawa Overview Basic Background Epigene.cs in general Epigene.cs in cancer Epigene.cs

More information

Considera*ons when undergoing personal genotyping

Considera*ons when undergoing personal genotyping Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for

More information

DawnRank: discovering personalized driver genes in cancer

DawnRank: discovering personalized driver genes in cancer Hou and Ma Genome Medicine 2014, 6:56 METHOD Open Access DawnRank: discovering personalized driver genes in cancer Jack P Hou 1,2 and Jian Ma 1,3* Abstract Large-scale cancer genomic studies have revealed

More information

Clasificación Molecular del Cáncer de Próstata. JM Piulats

Clasificación Molecular del Cáncer de Próstata. JM Piulats Clasificación Molecular del Cáncer de Próstata JM Piulats Introduction The Gleason score is the major method for prostate cancer tissue grading and the most important prognostic factor in this disease.

More information

Novel treatments for SCC Andrés Felipe Cardona, MD MS PhD.

Novel treatments for SCC Andrés Felipe Cardona, MD MS PhD. Novel treatments for SCC Andrés Felipe Cardona, MD MS PhD. Clinical and Transla,onal Oncology Group Ins,tute of Oncology, Fundación Santa fe de Bogotá Clinical Epidemiology Cochrane Colombian Branch /

More information

Cancer Genomics and Personalized Oncology. Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group

Cancer Genomics and Personalized Oncology. Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group Cancer Genomics and Personalized Oncology Dirce M Carraro, PhD Scien0st, Head of Genomics and Biology Molecular Group Cancer in Brazil 600,000 new cases/year Popula0on: 210,867,959 Number of new cases:

More information

Results and Discussion of Receptor Tyrosine Kinase. Activation

Results and Discussion of Receptor Tyrosine Kinase. Activation Results and Discussion of Receptor Tyrosine Kinase Activation To demonstrate the contribution which RCytoscape s molecular maps can make to biological understanding via exploratory data analysis, we here

More information

Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties

Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties by Combining Topological and Data-Driven Properties A. K. M. Azad, Hyunju Lee* School of Information and Communications, Gwangju Institute of Science and Technology, Gwangju, South Korea Abstract Recently,

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

Transcriptome and isoform reconstruc1on with short reads. Tangled up in reads

Transcriptome and isoform reconstruc1on with short reads. Tangled up in reads Transcriptome and isoform reconstruc1on with short reads Tangled up in reads Topics of this lecture Mapping- based reconstruc1on methods Case study: The domes1c dog De- novo reconstruc1on method Trinity

More information

Structural Variation and Medical Genomics

Structural Variation and Medical Genomics Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,

More information

Causes of variability in developmental disorders

Causes of variability in developmental disorders Causes of variability in developmental disorders Is the medical risk model appropriate for understanding behavioural deficits? Michael Thomas Birkbeck College Workshop: Developmental disorders: co- morbidity,

More information

Identification of Tissue Independent Cancer Driver Genes

Identification of Tissue Independent Cancer Driver Genes Identification of Tissue Independent Cancer Driver Genes Alexandros Manolakos, Idoia Ochoa, Kartik Venkat Supervisor: Olivier Gevaert Abstract Identification of genomic patterns in tumors is an important

More information

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review

More information

Why Pathway/Network Analysis?

Why Pathway/Network Analysis? 6/8/16 More Depth on Pathway and Network Analysis Lincoln Stein Why Pathway/Network Analysis? Drama@c data size reduc@on: 1000 s of genes => dozens of pathways. Increase sta@s@cal power by reducing mul@ple

More information

The Cancer Genome Atlas & International Cancer Genome Consortium

The Cancer Genome Atlas & International Cancer Genome Consortium The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1

More information

OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies

OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...

More information

NGS in tissue and liquid biopsy

NGS in tissue and liquid biopsy NGS in tissue and liquid biopsy Ana Vivancos, PhD Referencias So, why NGS in the clinics? 2000 Sanger Sequencing (1977-) 2016 NGS (2006-) ABIPrism (Applied Biosystems) Up to 2304 per day (96 sequences

More information

Interpreting Diverse Genomic Data Using Gene Sets

Interpreting Diverse Genomic Data Using Gene Sets Interpreting Diverse Genomic Data Using Gene Sets giovanni parmigiani@dfci.harvard.edu FHCRC February 2012 Gene Sets Leary 2008 PNAS Alterations in the combined FGF, EGFR, ERBB2 and PIK3 pathways. Red:

More information

Network-assisted data analysis

Network-assisted data analysis Network-assisted data analysis Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu Protein identification in shotgun proteomics Protein digestion LC-MS/MS Protein

More information

arxiv: v1 [cs.lg] 25 Jan 2016

arxiv: v1 [cs.lg] 25 Jan 2016 A new correlation clustering method for cancer mutation analysis Jack P. Hou 1,2,, Amin Emad 3,, Gregory J. Puleo 3, Jian Ma 1,4,*, and Olgica Milenkovic 3,* arxiv:1601.06476v1 [cs.lg] 25 Jan 2016 1 Department

More information

J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam, the Netherlands

J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam, the Netherlands Inherited arrhythmia syndromes I: What you always wanted to know, but were afraid to ask: The basics of inherited arrhythmia syndromes and gene:cs J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam,

More information

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA Giuseppe Narzisi, PhD Schatz Lab November 14, 2013 Micro-Assembly Approach to detect INDELs 2 Outline Scalpel micro-assembly pipeline

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

EXTRACTING SIGNIFICANT SAMPLE-SPECIFIC CANCER MUTATIONS USING THEIR PROTEIN INTERACTIONS

EXTRACTING SIGNIFICANT SAMPLE-SPECIFIC CANCER MUTATIONS USING THEIR PROTEIN INTERACTIONS EXTRACTING SIGNIFICANT SAMPLE-SPECIFIC CANCER MUTATIONS USING THEIR PROTEIN INTERACTIONS LIVIU BADEA University Politehnica Bucharest and Bioinformatics Group, ICI 8-10 Averescu Blvd, Bucharest, Romania

More information

Gene+c fate mapping. x loxp. Foxp3 3 UTR ROSA26 RFP IRES GFP CRE. STOP loxp. Stable Foxp3 expression. Foxp3 expression in new Treg.

Gene+c fate mapping. x loxp. Foxp3 3 UTR ROSA26 RFP IRES GFP CRE. STOP loxp. Stable Foxp3 expression. Foxp3 expression in new Treg. 1 Introduc+on (CD4 + CD25 + Foxp3 + )are indispensable for immune homeostasis. Muta+ons in Foxp3 gene leads to fatal autoimmune disorder. Condi+onal dele+on of Foxp3 reprograms cells into pathogenic Th

More information

The Hierarchical Organization of Normal and Malignant Hematopoiesis

The Hierarchical Organization of Normal and Malignant Hematopoiesis The Hierarchical Organization of Normal and Malignant Hematopoiesis NORMAL Hematopoie2c Stem Cell (HSC) Leukemia Stem Cells (LSC) MPP MLP CMP Leukemic Progenitors MEP GMP B/NK ETP Leukemic Blasts Erythrocytes

More information

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics

More information

The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley

The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley The Cancer Genome Atlas Pan-cancer analysis Katherine A. Hoadley Department of Genetics Lineberger Comprehensive Cancer Center The University of North Carolina at Chapel Hill What is TCGA? The Cancer Genome

More information

Inherited breast and ovarian cancer

Inherited breast and ovarian cancer Inherited breast and ovarian cancer Pr François Duhoux Medical Oncology and Center for Human Genetics Breast Incidence - Mortality.be: 147.5 29.5 Life9me risk : 12% IARC EUCAN Fact Sheets 2 1 Breast cancer

More information

Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models

Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models Steven A McCarroll, PhD Stanley Center for Psychiatric Research, Broad Ins7tute Department of Gene7cs, Harvard Medical School

More information

MolEcular Taxonomy of BReast cancer International Consortium (METABRIC)

MolEcular Taxonomy of BReast cancer International Consortium (METABRIC) PERSPECTIVE 1 LARGE SCALE DATASET EXAMPLES MolEcular Taxonomy of BReast cancer International Consortium (METABRIC) BC Cancer Agency, Vancouver Samuel Aparicio, PhD FRCPath Nan and Lorraine Robertson Chair

More information

Cancer troublemakers: a tale of usual suspects and novel villains

Cancer troublemakers: a tale of usual suspects and novel villains Cancer troublemakers: a tale of usual suspects and novel villains Abel González-Pérez and Núria López-Bigas Biomedical Genomics Group Lab web: http://bg.upf.edu Driver genes/mutations: the troublemakers

More information

Insights from Sequencing the Melanoma Exome

Insights from Sequencing the Melanoma Exome Insights from Sequencing the Melanoma Exome Michael Krauthammer, MD PhD, December 2 2015 Yale University School Yof Medicine 1 2012 Exome Screens and Results Exome Sequencing of 108 sun-exposed melanomas

More information

Carcinoma mammario triple nega0ve Nuove acquisizioni biologiche. Giuseppe Curigliano MD PhD UNIMI & IEO

Carcinoma mammario triple nega0ve Nuove acquisizioni biologiche. Giuseppe Curigliano MD PhD UNIMI & IEO Carcinoma mammario triple nega0ve Nuove acquisizioni biologiche Giuseppe Curigliano MD PhD UNIMI & IEO Outline San Antonio Breast Cancer Symposium, December 5-9, 2017 The year of DNA Repair targe?ng Olaparib

More information

IDENTIFYING MASTER REGULATORS OF CANCER AND THEIR DOWNSTREAM TARGETS BY INTEGRATING GENOMIC AND EPIGENOMIC FEATURES

IDENTIFYING MASTER REGULATORS OF CANCER AND THEIR DOWNSTREAM TARGETS BY INTEGRATING GENOMIC AND EPIGENOMIC FEATURES IDENTIFYING MASTER REGULATORS OF CANCER AND THEIR DOWNSTREAM TARGETS BY INTEGRATING GENOMIC AND EPIGENOMIC FEATURES OLIVIER GEVAERT Radiology, Stanford, 1201 Welch Road Stanford, CA 94305 Email: olivier.gevaert@stanford.edu

More information

Valida5on of a Microsatellite Instability Assay by NGS

Valida5on of a Microsatellite Instability Assay by NGS Valida5on of a Microsatellite Instability Assay by NGS Mark R. Miglarese, Ph.D. VP R&D 1 Caris Life Sciences 230,000+ tests performed in 2016 Headquarters: Irving, Texas Laboratory: Phoenix, Arizona 66,000

More information

Genomic tests to personalize therapy of metastatic breast cancers. Fabrice ANDRE Gustave Roussy Villejuif, France

Genomic tests to personalize therapy of metastatic breast cancers. Fabrice ANDRE Gustave Roussy Villejuif, France Genomic tests to personalize therapy of metastatic breast cancers Fabrice ANDRE Gustave Roussy Villejuif, France Future application of genomics: Understand the biology at the individual scale Patients

More information

Integrated genomic analyses of ovarian carcinoma

Integrated genomic analyses of ovarian carcinoma Integrated genomic analyses of ovarian carcinoma The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published Publisher Bell,

More information

Nature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from

Nature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from Supplementary Figure 1 SEER data for male and female cancer incidence from 1975 2013. (a,b) Incidence rates of oral cavity and pharynx cancer (a) and leukemia (b) are plotted, grouped by males (blue),

More information

Predicting Kidney Cancer Survival from Genomic Data

Predicting Kidney Cancer Survival from Genomic Data Predicting Kidney Cancer Survival from Genomic Data Christopher Sauer, Rishi Bedi, Duc Nguyen, Benedikt Bünz Abstract Cancers are on par with heart disease as the leading cause for mortality in the United

More information

Taking a closer look at trio designs and unscreened controls in the GWAS era

Taking a closer look at trio designs and unscreened controls in the GWAS era Taking a closer look at trio designs and unscreened controls in the GWAS era PGC Sta8s8cal Analysis Call, November 4th 015 Wouter Peyrot, MD, Psychiatrist in training, PhD candidate Professors Brenda Penninx,

More information

Expert-guided Visual Exploration (EVE) for patient stratification. Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland

Expert-guided Visual Exploration (EVE) for patient stratification. Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland Expert-guided Visual Exploration (EVE) for patient stratification Hamid Bolouri, Lue-Ping Zhao, Eric C. Holland Oncoscape.sttrcancer.org Paul Lisa Ken Jenny Desert Eric The challenge Given - patient clinical

More information

Identifying Causal Genes and Dysregulated Pathways in Complex Diseases

Identifying Causal Genes and Dysregulated Pathways in Complex Diseases Identifying Causal Genes and Dysregulated Pathways in Complex Diseases Yoo-Ah Kim, Stefan Wuchty, Teresa M. Przytycka* National Center for Biotechnology Information, National Library of Medicine, National

More information

Gene Ontology and Functional Enrichment. Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein

Gene Ontology and Functional Enrichment. Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein Gene Ontology and Functional Enrichment Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein The parsimony principle: A quick review Find the tree that requires the fewest

More information

Dr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach

Dr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach Dr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach Department of Health Sciences Section of Biostatistics University of Genoa, Italy Mul%ple

More information

Protein Domain-Centric Approach to Study Cancer Somatic Mutations from High-throughput Sequencing Studies

Protein Domain-Centric Approach to Study Cancer Somatic Mutations from High-throughput Sequencing Studies Protein Domain-Centric Approach to Study Cancer Somatic Mutations from High-throughput Sequencing Studies Dr. Maricel G. Kann Assistant Professor Dept of Biological Sciences UMBC 2 The term protein domain

More information

DGPathinter: a novel model for identifying driver genes via knowledge-driven matrix factorization with prior knowledge from interactome and pathways

DGPathinter: a novel model for identifying driver genes via knowledge-driven matrix factorization with prior knowledge from interactome and pathways DGPathinter: a novel model for identifying driver genes via knowledge-driven matrix factorization with prior knowledge from interactome and pathways Jianing Xi, *, Minghui Wang,2, * and Ao Li,2 School

More information

Pa#ern recogni,on and neuroimaging in psychiatry

Pa#ern recogni,on and neuroimaging in psychiatry Pa#ern recogni,on and neuroimaging in psychiatry Janaina Mourao-Miranda Machine Learning and Neuroimaging Lab Max Planck UCL Centre for Computa=onal Psychiatry and Ageing Research Outline Supervised learning

More information

Comparing Multifunctionality and Association Information when Classifying Oncogenes and Tumor Suppressor Genes

Comparing Multifunctionality and Association Information when Classifying Oncogenes and Tumor Suppressor Genes 000 001 002 003 004 005 006 007 008 009 010 011 012 013 014 015 016 017 018 019 020 021 022 023 024 025 026 027 028 029 030 031 032 033 034 035 036 037 038 039 040 041 042 043 044 045 046 047 048 049 050

More information

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015 Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a

More information

Gene-microRNA network module analysis for ovarian cancer

Gene-microRNA network module analysis for ovarian cancer Gene-microRNA network module analysis for ovarian cancer Shuqin Zhang School of Mathematical Sciences Fudan University Oct. 4, 2016 Outline Introduction Materials and Methods Results Conclusions Introduction

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28

More information

Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries

Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Advances in Brain Tumor Research: Leveraging BIG data for BIG discoveries Jill Barnholtz-Sloan, PhD Associate Professor & Associate Director for Bioinformatics and Translational Informatics jsb42@case.edu

More information

Small RNAs and how to analyze them using sequencing

Small RNAs and how to analyze them using sequencing Small RNAs and how to analyze them using sequencing Jakub Orzechowski Westholm (1) Long- term bioinforma=cs support, Science For Life Laboratory Stockholm (2) Department of Biophysics and Biochemistry,

More information

Glioblastoma pathophysiology: or a

Glioblastoma pathophysiology: or a Glioblastoma pathophysiology: A or a? M.J. van den Bent The Brain Tumor Center at Erasmus MC Cancer Center Rotterdam, the Netherlands Pathophysiology: pathophysiology seeks to explain the physiological

More information

S1 Appendix: Figs A G and Table A. b Normal Generalized Fraction 0.075

S1 Appendix: Figs A G and Table A. b Normal Generalized Fraction 0.075 Aiello & Alter (216) PLoS One vol. 11 no. 1 e164546 S1 Appendix A-1 S1 Appendix: Figs A G and Table A a Tumor Generalized Fraction b Normal Generalized Fraction.25.5.75.25.5.75 1 53 4 59 2 58 8 57 3 48

More information

Transcript reconstruction

Transcript reconstruction Transcript reconstruction Summary I Data types, file formats and utilities Annotation: Genomic regions Genes Peaks bedtools Alignment: Map reads BAM/SAM Samtools Aggregation: Summary files Wig (UCSC) TDF

More information

Multiplexed Cancer Pathway Analysis

Multiplexed Cancer Pathway Analysis NanoString Technologies, Inc. Multiplexed Cancer Pathway Analysis for Gene Expression Lucas Dennis, Patrick Danaher, Rich Boykin, Joseph Beechem NanoString Technologies, Inc., Seattle WA 98109 v1.0 MARCH

More information

Nature Biotechnology: doi: /nbt.1904

Nature Biotechnology: doi: /nbt.1904 Supplementary Information Comparison between assembly-based SV calls and array CGH results Genome-wide array assessment of copy number changes, such as array comparative genomic hybridization (acgh), is

More information

HIT ndrive: Multi-driver Gene Prioritization Based on Hitting Time

HIT ndrive: Multi-driver Gene Prioritization Based on Hitting Time HIT ndrive: Multi-driver Gene Prioritization Based on Hitting Time Raunak Shrestha 1,2,, Ermin Hodzic 3,, Jake Yeung 2,4,, Kendric Wang 2, Thomas Sauerwald 5, Phuong Dao 6, Shawn Anderson 2, Himisha Beltran

More information

Expanded View Figures

Expanded View Figures Molecular Systems iology Tumor CNs reflect metabolic selection Nicholas Graham et al Expanded View Figures Human primary tumors CN CN characterization by unsupervised PC Human Signature Human Signature

More information

De Novo Viral Quasispecies Assembly using Overlap Graphs

De Novo Viral Quasispecies Assembly using Overlap Graphs De Novo Viral Quasispecies Assembly using Overlap Graphs Alexander Schönhuth joint with Jasmijn Baaijens, Amal Zine El Aabidine, Eric Rivals Milano 18th of November 2016 Viral Quasispecies Assembly: HaploClique

More information

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Female Reproduc.ve System. Kris.ne Kra7s, M.D. Female Reproduc.ve System Kris.ne Kra7s, M.D. Female Reproduc.ve System Outline Cervix Uterus Ovaries Breast Female Reproduc.ve System Outline Cervix Cervical carcinoma Cervical Carcinoma Once the most

More information

Clinical Grade Biomarkers in the Genomic Era Observations & Challenges

Clinical Grade Biomarkers in the Genomic Era Observations & Challenges Clinical Grade Biomarkers in the Genomic Era Observations & Challenges IOM Committee on Policy Issues in the Clinical Development & Use of Biomarkers for Molecularly Targeted Therapies March 31-April 1,

More information

NGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin

NGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin NGS, Cancer and Bioinforma;cs 1 NGS and Clinical Oncology NGS in hereditary cancer genome tes;ng BRCA1/2 (breast/ovary cancer) XPC (melanoma) ERCC1 (colorectal cancer) NGS for personalized cancer treatment

More information

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes

More information

NEXT GENERATION SEQUENCING. R. Piazza (MD, PhD) Dept. of Medicine and Surgery, University of Milano-Bicocca

NEXT GENERATION SEQUENCING. R. Piazza (MD, PhD) Dept. of Medicine and Surgery, University of Milano-Bicocca NEXT GENERATION SEQUENCING R. Piazza (MD, PhD) Dept. of Medicine and Surgery, University of Milano-Bicocca SANGER SEQUENCING 5 3 3 5 + Capillary Electrophoresis DNA NEXT GENERATION SEQUENCING SOLEXA-ILLUMINA

More information

Early life metal exposure and epigene4cs: a transdisciplinary approach

Early life metal exposure and epigene4cs: a transdisciplinary approach Early life metal exposure and epigene4cs: a transdisciplinary approach Alison P. Sanders, PhD Postdoctoral Fellow Department of Preven4ve Medicine Icahn School of Medicine at Mount Sinai Trans- disciplinary

More information

Glioblastoma mul,forme

Glioblastoma mul,forme Glioblastoma mul,forme Glioblastoma mul,forme (GBM), or Glioblastoma, or Grade IV Astrocytoma is the most common and most aggressive malignant primary brain tumor. GBM is usually involving glial cells,

More information

Module 3: Pathway and Drug Development

Module 3: Pathway and Drug Development Module 3: Pathway and Drug Development Table of Contents 1.1 Getting Started... 6 1.2 Identifying a Dasatinib sensitive cancer signature... 7 1.2.1 Identifying and validating a Dasatinib Signature... 7

More information

What s in your genes? Whole genome sequencing and its impact on personalized medicine

What s in your genes? Whole genome sequencing and its impact on personalized medicine What s in your genes? Whole genome sequencing and its impact on personalized medicine Adrianna San Roman Clare Malone Leah Liu Photo by Micah Baldwin Personalized Medicine Tailoring of medical care based

More information